|本期目录/Table of Contents|

[1]丁桃容,刘婷婷,宗海娟.AECOPD并发肺部感染的危险因素及病原菌分析[J].中华肺部疾病杂志,2022,(02):209-211.[doi:10.3877/cma.j.issn.1674-6902.2022.02.016]
点击复制

AECOPD并发肺部感染的危险因素及病原菌分析(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2022年02期
页码:
209-211
栏目:
临床研究
出版日期:
2022-04-20

文章信息/Info

Title:
-
作者:
丁桃容; 刘婷婷; 宗海娟
226500 江苏,如皋市人民医院呼吸内科
Author(s):
-
关键词:
急性加重期; 肺疾病; 慢性阻塞性;  肺部感染;  病原菌
Keywords:
-
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2022.02.016
摘要:
目的 分析慢性阻塞性肺疾病急性加重期(AECOPD)患者并发肺部感染的危险因素及其病原菌分布特点。方法 选择2019年1月至2021年12月我院收治的AECOPD并发肺部感染患者66例,多因素Logistic回归分析AECOPD患者并发肺部感染的危险因素,取患者痰液标本,采用全自动微生物分析其病原菌构成。结果 66例患者共分离出8种131株病原菌,其中肺炎克雷伯菌32例(24.43); 多因素Logistic回归分析显示,年龄>60岁、入侵性操作、并发糖尿病、低蛋白血症<30 g/L、抗菌药物使用时间≥15 d是AECOPD患者肺部感染发生的危险因素(P<0.05)。结论 AECOPD肺部感染患者病原菌主要以肺炎克雷伯菌、铜绿假单细胞菌、金黄色葡萄球菌等为主,年龄、糖尿病、入侵性操作、低蛋白血症及抗菌药物使用情况是影响AECOPD患者肺部感染的重要因素。
Abstract:
-

参考文献/References:

1 李艳燕, 赛亚飞, 任 腾, 等. 机械通气的慢性阻塞性肺疾病急性加重期患者气道分泌物的细菌学特点[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(3): 371-373.
2 Yao C, Wang L, Shi F, et al. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure[J]. Int JMed Sci, 2021, 18(7): 1592-1599.
3 Tung LF, Shen SY, Shi HH, et al. Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study[J]. Respir Res, 2020, 21(1): 84.
4 李永红, 李宏科, 王 芳, 等. 慢性阻塞性肺疾病患者合并侵袭性肺曲霉菌感染危险因素的Meta分析[J]. 中国抗生素杂志, 2021, 46(2): 170-176.
5 Guan X, Yuan Y, Wang G, et al. Ginsenoside Rg3 ameliorates acute exacerbation of COPD by suppressing neutrophil migration[J]. Int Immunopharmacol, 2020, 83: 106449.
6 陈芳芳, 张 芳, 张秀芹, 等. COPD合并肺部感染危险因素及血浆LncRNA NEAT1表达水平[J]. 中华医院感染学杂志, 2021, 31(17): 2673-2677.
7 余来顺, 谢守宁, 妥亚军, 等. COPD患者肺部感染的病原学及多药耐药铜绿假单胞菌感染危险因素[J]. 中华医院感染学杂志, 2021, 31(18): 2759-2762.
8 王凤燕, 张冬莹, 梁振宇, 等. 面向全科医生的《慢性阻塞性肺疾病诊治指南(2021年修订版)》解读[J]. 中国全科医学, 2021, 24(29): 3660-3663, 3677.
9 何礼贤. 《肺真菌病诊断和治疗专家共识》解读[J]. 中国实用内科杂志, 2008, 28(8): 635-636.
10 Riley CM, Sciurba FC. Diagnosis and outpatient management of chronic obstructive pulmonary disease: A review[J]. JAMA, 2019, 321(8): 786-797.
11 Lewis A, Axson EL, Potts J, et al. Protocol for a systematic literature review and network meta-analysis of the clinical benefit of inhaled maintenance therapies in chronic obstructive pulmonary disease[J]. Bmj Open, 2019, 9(2): 216-220.
12 沈奕播, 仇 晟, 李 琦. 慢性阻塞性肺疾病急性加重患者预后危险因素分析[J/CD]. 中华肺部疾病杂志(电子版), 2018, 11(3): 344-346.
13 Jgnatova GL, AntonovVN, et al. Analysis of compliance dynamics in patients with chronic obstructive pulmonary disease on the background of vaccination against pneumococcal infection[J]. Ter Arkh, 2018, 90(3): 47-52.
14 Mannan H, Foo SW, Cochrane B. Does device matter for inhaled therapies in advanced chronic obstructive pulmonary disease(COPD)? A comparative trial of two devices[J]. BMC Res Notes, 2019, 12(1): 94-99.
15 Moleres J, Fernández-CalvetAA, Ehrlich A, et al. Antagonistic pleiotropy in the bifunctional surface protein fadL(OmpP1)during adaptation of haemophilus influenzaeto chronic lung infection associated with chronic obstructive pulmonary disease[J]. mBio, 2018, 9(5): 18-20.
16 Wang W. Sleep and sleep related breathing disorders in chronic obstructive pulmonary disease[J]. Zhonghua Yi Xue Za Zhi, 2019, 99(6): 411-413.
17 郎燕芳, 俞志红, 陆晓玲, 等. 慢阻肺合并睡眠呼吸暂停综合征老年患者肺感染的病原学及相关因素分析[J]. 中华医院感染学杂志, 2017, 27(23): 5329-5332, 5356.
18 亓慧琴, 张连莲, 邢利平, 等. 慢性阻塞性肺疾病患者应用异丙托溴铵联合乙酰半胱氨酸治疗前后血清中 TGF-β和 MMP-9水平的变化及其临床意义[J]. 吉林大学学报(医学版), 2016, 42(4): 777-782.
19 Lin YL, Chen YF. Relationship between fungal infection and AECOPD and its risk factors[J]. J Clin Pul Med, 2019, 15(10): 702-705.
20 Njoku CM, Alqahtani JS, Wimmer BC, et al. Risk factors and associated outcomes of hospital readmission in COPD: A systematic review[J]. Respir Med, 2020, 173(1): 105988.
21 Seo JH, Lee JY. Novel nomogram based on risk factors of chronic obstructive pulmonary disease(COPD)using a nave Bayesian classifier model[J]. J Korean Statistic Soci, 2019, 48(2): 278-286.
22 Stellefson M, Paige SR, Barry AE, et al. Risk factors associated with physical and mental distress in people who report a COPD diagnosis: latent class analysis of 2016 behavioral risk factor surveillance system data[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14(3): 16-19.
23 王 芳, 刘 琼, 范久波, 等. 不同病程的糖尿病患者合并肺部感染病原菌分布及耐药性比较[J]. 中国感染控制杂志, 2019, 18(10): 910-916.
24 黄 鸿, 黄 芪, 徐 海, 等. 老年糖尿病并发肺部感染病原学及影响因素[J]. 中华医院感染学杂志, 2021, 31(8): 1179-1182.
25 Wang G, Kull I, Bergstrm A, et al. Early-life risk factors for reversible and irreversible airflow limitation in young adults: Findings from the BAMSE birth cohort[J]. Thorax, 2020, 76(5): 215884.
26 张瑞昕, 李 凤, 黄丽红, 等. 重症脑卒中患者肺部感染与营养相关的危险因素分析[J]. 中国实用护理杂志, 2021, 37(34): 2644-2649.
27 闵 丹, 蔡敏慧, 陈 敏. 老年重症肺部感染患者应用肠内和肠外营养支持的疗效比较[J]. 中国实用护理杂志, 2017, 33(25): 1939-1942.
28 Sampaio MS, Vieira W, ÍDM Bernardino, et al. Chronic obstructive pulmonary disease as a risk factor for suicide: A systematic review and meta-analysis[J]. Respir Med, 2019, 151(6): 11-18.
29 Castañ-Abad MT, Josep MC, Pere G, et al. Diabetes as a risk factor for severe exacerbation and death in patients with COPD: a prospective cohort study[J]. Eur J Public Health, 2020, 30(4): 822-827.

备注/Memo

备注/Memo:
通信作者: 丁桃容, Email: 948351297@qq.com
更新日期/Last Update: 2022-04-20